SEARCH

UPCOMING LIVE SEMINARS
 
Auditing Techniques for Clinical Research Professionals
October 23-24, 2014
San Francisco, CA
Monitoring Clinical Drug Studies: Advanced
November 13-14, 2014
San Francisco, CA






Electronic Medical Records April 2010

Course Description

Current societal events have influenced the increase use of electronic medical records, one being the promotion of a national electronic medical record. More and more research sites are using an electronic medical record (EMR) for all or part of their case histories for research subjects.  The industry has defined the characteristics that source documents in any form must include, and 21 CFR Part 11 includes standards for electronic source data.  Challenges in monitoring the original source document have been growing and unaddressed in many situations.  FDA's release of a final guidance document for 21 CFR Part 11 supports certain characteristics that EMRs should include, but many site electronic records do not meet the requirements.  This course will discuss assessment of EMRs, ideal monitoring vs. contingency planning, and risk management. 

VideoPreview

 

Learning Objectives

  • Define source documents (FDA & ICH)
  • Explain required characteristics for source documents in any form
  • Describe requirements of electronic source documents (21 CFR Part 11)
  • Apply these concepts to electronic medical records at research sites
  • Implement contingency planning for electronic source document deficiencies
  • Manage site and sponsor activities regarding electronic medical records

Who Should Attend

  • Investigators and CRCs
  • Device and Drug Study CRAs
  • CRA and Project Managers
  • Quality Assurance

Instructor 

Sandra SAM Sather, MS, BSN, CCRA, CCRC

Click here for complete trainer biographies

Course Length Time

2.5 hours; 9:00 - 11:30 p.m. Eastern

Course Dates 

April 19 2010     

Hold this course at your company!
For more information, contact Naila Ganatra at (215) 413-2471